Mt. Vernon Register-News

Community News Network

March 5, 2014

Lilly's diabetes drug rejected by FDA

NEW YORK — A diabetes pill developed by Eli Lilly and Boehringer Ingelheim was rejected by U.S. regulators because of previously disclosed manufacturing deficiencies at a German plant that hadn't been resolved.

The Food and Drug Administration inspected Boehringer's Ingelheim am Rhein facility in 2012 and warned the Ingelheim- based company of the faults in May 2013. No new clinical studies will be needed to approved the drug, called empagliflozin, the companies said Wednesday in a statement.

"The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured," the companies said. The FDA won't approved the drug until the problems are fixed.

About 24 million people in the United States have diabetes, a condition often driven by obesity where the body loses its ability to process sugar.

Empagliflozin is part of a class of drugs that includes Johnson & Johnson's Invokana and AstraZeneca's Forxiga. The drugs help the body get rid of sugar through the kidneys.

The Lilly-Boehringer drug is projected to sell $295 million for Lilly in 2019, according to analyst estimates compiled by Bloomberg.

The FDA re-inspection of Boehringer's plant is continuing, said Emily Baier, a spokeswoman for the company. "The inspection is reviewing aspects related to production, processes, quality assurance and other related areas," said in an email. It could take up to six months after the inspection for the FDA to decide whether the problems have been fixed.

The 2012 inspection found what the FDA called "significant violations of current manufacturing practice" at the plant. They included a failure to look into issues with the active ingredients of drug made there as well as contamination problems that also weren't investigated.

The warning letter last year didn't specifically mention empagliflozin, Philip Johnson, Lilly's vice president of investor relations, said on a Jan. 7 conference call.

"Empagliflozin was not specifically cited in that warning letter," Johnson said. "There was other commercial production that was specifically referenced. Boehringer Ingelheim has been working through this with the FDA."



 

1
Text Only
Community News Network
  • Africa goes medieval in its fight against Ebola

    As the Ebola epidemic claims new victims at an ever-increasing rate, African governments in Sierra Leone, Guinea and Liberia have instituted a "cordon sanitaire," deploying troops to forcibly isolate the inhabitants in an area containing most of the cases.

    August 18, 2014

  • Democrat? Republican? There's an app for that

    If you're a Republican, you might want to think twice before buying Lipton Iced Tea, and forget about Starbucks coffee. If you're a Democrat, put down that Reese's Peanut Butter Cup, and throw away the cylinder of Quaker Oats in your pantry.

    August 18, 2014

  • Five myths about presidential vacations

    In the nuclear age, presidents may have only minutes to make a decision that could affect the entire world. They don't so much leave the White House as they take a miniature version of it with them wherever they go.

    August 15, 2014

  • weightloss.jpg The scales of injustice: Weight loss differs between men, women

    You're not imagining it: There really are differences between the way men and women diet, lose weight and respond to exercise.

    August 13, 2014 1 Photo

  • Drug dealers going corporate

    A top federal official on Tuesday said that 105 banks and credit unions are doing business with legal marijuana sellers, suggesting that federal rules giving financial institutions the go-ahead to provide services to dealers are starting to work.

    August 13, 2014

  • wwimemorial.jpg The benefit of World War I omission on the Washington Mall

    By 1982, when the Vietnam Veterans Memorial opened on the National Mall, something had shifted in the way we remember our wars. A national memorial, prominently placed on the nation's most symbolically significant public space, came to seem like an essential dignity offered to veterans, their families and the memory of those who gave their lives. But there is an exception.

    August 11, 2014 1 Photo

  • In Japan, ramen aficionados worry their favorite dish is coming off the boil

    "The ramen boom has ended," said Ivan Orkin, a New Yorker who first traveled to Japan in the 1980s and now owns two noodle-soup restaurants in Tokyo. "A boom implies that there are new avenues and new growth to pursue, and that's not the case in Japan anymore."

    August 11, 2014

  • Ronnie Ellis: U.S. Senate race trail long and interesting

    By Ronnie Ellis/CNHI News Service

    FRANKFORT — Last week was a long one, endured under the onslaught of an awful summer cold and played out across the commonwealth. It began in Fancy Farm and ended it in Corbin with a trip to Hazard in between.

    August 9, 2014

  • Senate race becomes family affair

    By LANA BELLAMY
    CNHI NEWS SERVICE
    PAINTSVILLE — U.S. Senate Minority Leader Mitch McConnell got personal on Friday while calling a report inaccurate concerning his wife’s role as a board member in an organization that funds anti-coal efforts.

    August 9, 2014

  • Dennis Beighley led out of courthouse Mother, grandparents face attempted murder charges in starvation case

    Cheers and applause erupted in a courtroom when a pregnant mother from Pennsylvania accused of starving her then-7-year-old son was remanded to jail, along with the boy’s grandparents.

    August 8, 2014 2 Photos

Twitter Updates
Facebook
Stocks